Search

everythinglearnresearchcommunity

for

Search:↓

A new method was created to analyze certain chemicals in the urine of alopecia areata patients, revealing they have higher metanephrine content. This method can also be used for other related diseases.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Baricitinib significantly regrows hair in severe alopecia areata patients.

RDW is a useful, cost-effective tool for diagnosing and monitoring various diseases.

A new method uses expert reviews of home videos to objectively assess children's developmental milestones in single-arm trials.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Newborn screening for biotinidase deficiency is effective in preventing severe complications.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

A hair test shows promise for early mood disorder diagnosis.

Patients are most satisfied with tummy tucks when they like the results, the staff, and the care after surgery.

Certain blood markers, especially MLR, can help diagnose alopecia areata.

The DHT immunoassay is unreliable due to high cross-reactivity with testosterone.

Children with alopecia areata have lower BDNF levels, linked to worse symptoms and quality of life.

Simple methods using DHT levels effectively assess compliance.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Nanoparticles don't penetrate intact skin but can enter through pores or damaged skin.

Cuscuta reflexa extract may help treat hair loss caused by hormones.